Determinants of Response to Interleukin‐10 Receptor Blockade Immunotherapy in Experimental Visceral Leishmaniasis

Abstract
In established Leishmania donovani visceral infection in normal mice, anti-interleukin (IL)-10 receptor (IL-10R) monoclonal antibody (MAb) treatment

This publication has 0 references indexed in Scilit: